Company Filing History:
Years Active: 1977
Title: Werner Schulz: Innovator in Pharmaceutical Chemistry
Introduction
Werner Schulz is a notable inventor based in Ingelheim am Rhein, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on compounds that have potential applications in medicine.
Latest Patents
One of Schulz's key patents is titled "Quaternary N-.beta.-substituted N-alkyl-nortropine benzilates." This patent involves compounds of the formula ##STR1##, wherein one of R and R' is an alkyl group containing 1 to 4 carbon atoms. This invention showcases his expertise in developing novel chemical compounds that may have therapeutic benefits.
Career Highlights
Werner Schulz is associated with Boehringer Ingelheim GmbH, a leading global pharmaceutical company. His work at this esteemed organization has allowed him to focus on innovative research and development in the pharmaceutical sector.
Collaborations
Throughout his career, Schulz has collaborated with notable colleagues, including Rolf Banholzer and Rudolf Bauer. These partnerships have contributed to the advancement of research and the development of new pharmaceutical products.
Conclusion
Werner Schulz's contributions to pharmaceutical chemistry, particularly through his patent on quaternary compounds, highlight his role as an innovator in the field. His work continues to influence the development of new therapeutic agents.